Renhuang Pharmaceuticals, Inc. was founded in 1996 in Harbin, Heilongjiang province in Northeast China. In September 2006, the Company became a US listed public company through a reverse merger and began trading on the Over the Counter Bulletin Board under the ticker symbol “RHGP”.
Renhuang is a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines. The Company offers three major product lines including Siberian Ginseng (Acanthopanax) based natural medicinal products, biopharmaceutical products, and over-the-counter (OTC) Traditional Chinese Medicines (TCMs), representing roughly 78.0%, 11.1%, and 10.9%,respectively of total revenues. Renhuang‘s key product line is the Siberian Ginseng (Acanthopanax) based product series, a natural medicine effective in treating depression, melancholy, and other nerve regulating products. With control over an estimated 70% of China‘s natural raw materials of Siberian Ginseng (Acanthopanax), the Company possesses a sustainable competitive edge and, therefore, commands a dominant market position in Siberian Ginseng (Acanthopanax) based products.
The Company distributes its products through a multi-layered sales network of over 3,000 sales agents organized under 70 sales centers across 24 provinces that cover over 50% of greater China.
Renhuang has established a multi-channel research and development infrastructure composed of in-house researchers and a government approved post-doctoral work station. The Company also collaborates with well-known institutions and scientists to advance the scope of its research and development. The Company has achieved significant progress in the research and development of standard extraction and separation of effective components.
Renhuang has three manufacturing facilities producing over 200 types of nutritional and medicinal products in various forms. The Company strictly follows the international Good Manufacturing Practices (“GMP”) and all of the manufacturing facilities are GMP certified quality processes and systems by utilizing cutting-edge technologies, state-of-the-art equipment, and proprietary innovative and award winning processes.
As a fast-growing pharmaceutical company, Renhuang is committed to operational excellence and creation of long-term value for its shareholders. The Company values efficiency, innovation, and integrity and strives to advance the science and technology of the pharmaceutical industry for the greater benefit of humankind, while putting the interest of its consumers first. The Company aspires to share its knowledge of Chinese Traditional Medicine with the rest of the world. Renhuang is dedicated to the development of the pharmaceutical industry in China and the Company‘s goal is to be the world leader in natural therapeutics for treating depression, melancholy and nerve regulation.